Search Results Search Sort by RelevanceMost Recent Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. Medicine and Society Feb 2020 How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control? Justin M. List, MD, MAR, MSc and Jeremy M. O’Connor, MD, MHS Government and public-private coalitions have important roles in cancer surveillance in LMICs. AMA J Ethics. 2020;22(2):E147-155. doi: 10.1001/amajethics.2020.147. Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93. Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135. Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168. Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606.
Medicine and Society Feb 2020 How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control? Justin M. List, MD, MAR, MSc and Jeremy M. O’Connor, MD, MHS Government and public-private coalitions have important roles in cancer surveillance in LMICs. AMA J Ethics. 2020;22(2):E147-155. doi: 10.1001/amajethics.2020.147.
Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93.
Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135.
Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168.
Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.